CONNECT WITH US
Tech

Tech

Seattle startup Avante raises $30M to bring AI agents to corporate benefits teams

GeekWire logo

Published on

Add as a preferred source on Google
Seattle startup Avante raises $30M to bring AI agents to corporate benefits teams

Avante, the maker of an AI platform to help companies manage employee health care and other benefits, has landed a $30 million Series A round.

Frist Cressey Ventures led the round, with participation from Sorenson Capital, Hearst Ventures, Morgan Stanley Next Level Fund and existing investor Fuse. The new funding, announced Tuesday, brings Seattle-based Avante’s total raised to $40 million, following a $10 million seed round led by Fuse in 2024.

Benefits are one of employers’ biggest costs. Avante’s AI agents do work like comparing vendor contracts against actual claims, reviewing plan documents for errors and preparing for renewals. Employees can also use the platform to ask questions about their own coverage.

The startup plans to use the cash to expand internationally and develop more AI agents, building on a beta release of its “Ava Agents” last week.

Avante says it now has more than 70 customers, including Samsung Semiconductor, Real Chemistry, Zscaler and News Corp, and that bookings grew nearly fivefold over the past year. The platform reaches more than 385,000 employees and family members, according to the company.

Avante was founded in 2023 by CEO Rohan D’Souza; Carly Eckert, a physician and epidemiologist who serves as head of innovation and impact; and executive chairman Kabir Shahani, the co-CEO of Amperity.

D’Souza and Eckert previously worked as executives at health care automation company Olive AI, which shut down in 2023. The startup emerged from stealth in early 2024 and launched publicly in April 2025.



Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.